Critically ill COVID-19 individuals had a reduced IFN type I response and increased expression of inhibitory receptor LAIR-1 (leukocyte-associated immunoglobulin receptor 1) in monocytes (19%) despite the presence or absence of anti-IFN antibodies [158]. Here, IFNA1 is linked to COVID-19.